ALX Oncology

-$3.27 (-5.03%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ALX Oncology and other stocks, options, and ETFs commission-free!

About ALXO

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications.

CEO
Jaume Pons
Employees
23
Headquarters
Burlingame, California
Founded
2015

ALXO Key Statistics

Market Cap
2.47B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
213.86K
High Today
$64.56
Low Today
$60.26
Open Price
$64.56
Volume
184.13K
52 Week High
$117.45
52 Week Low
$28.01

ALXO Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
—

You May Also Like

TRP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure